PROMising developments in IPF patient-reported outcome measures
- PMID: 35027375
- DOI: 10.1183/13993003.02312-2021
PROMising developments in IPF patient-reported outcome measures
Conflict of interest statement
Conflict of interest: C.M. Nolan reports personal fees from Novartis, outside the submitted work. Conflict of interest: S.S. Birring reports personal fees from Boehringer Ingelheim, outside the submitted work.
Comment on
-
R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.Eur Respir J. 2022 Jan 13;59(1):2100917. doi: 10.1183/13993003.00917-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34112729
-
The use of online visual analogue scales in idiopathic pulmonary fibrosis.Eur Respir J. 2022 Jan 13;59(1):2101531. doi: 10.1183/13993003.01531-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34326190 Free PMC article.
Similar articles
-
New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?Curr Opin Pulm Med. 2016 Sep;22(5):434-41. doi: 10.1097/MCP.0000000000000294. Curr Opin Pulm Med. 2016. PMID: 27333428 Review.
-
Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.Lung. 2016 Apr;194(2):227-34. doi: 10.1007/s00408-016-9850-y. Epub 2016 Feb 9. Lung. 2016. PMID: 26861885
-
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.Chest. 2018 Jan;153(1):94-104. doi: 10.1016/j.chest.2017.09.052. Epub 2017 Oct 31. Chest. 2018. PMID: 29100885 Free PMC article. Clinical Trial.
-
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC. Am J Respir Crit Care Med. 2020. PMID: 32325005 Clinical Trial.
-
Patient expectations and experiences in idiopathic pulmonary fibrosis: implications of patient surveys for improved care.Expert Rev Respir Med. 2014 Apr;8(2):173-8. doi: 10.1586/17476348.2014.880056. Epub 2014 Jan 22. Expert Rev Respir Med. 2014. PMID: 24450476 Review.
Cited by
-
Patient-centered care in pulmonary fibrosis: access, anticipate, and act.Respir Res. 2024 Nov 1;25(1):395. doi: 10.1186/s12931-024-02997-7. Respir Res. 2024. PMID: 39487454 Free PMC article. Review.
-
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.Am J Respir Crit Care Med. 2024 Mar 15;209(6):647-669. doi: 10.1164/rccm.202312-2213SO. Am J Respir Crit Care Med. 2024. PMID: 38174955 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources